{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:34:12Z","timestamp":1762000452289,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pupt.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T03:00:18Z","timestamp":1506654018000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema"],"prefix":"10.1016","volume":"48","author":[{"given":"Masafumi","family":"Nojiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Nishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Osanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Toga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2017.09.004_bib1","doi-asserted-by":"crossref","first-page":"301695","DOI":"10.1155\/2011\/301695","article-title":"Phosphodiesterase type 4D gene polymorphism: association with the response to short-acting bronchodilators in paediatric asthma patients","volume":"2011","author":"Labuda","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.pupt.2017.09.004_bib2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1183\/09031936.00146310","article-title":"ADRB2 Gly16Arg polymorphism, asthma control and lung function decline","volume":"38","author":"Rebordosa","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2017.09.004_bib3","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/S0140-6736(07)61906-0","article-title":"Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies","volume":"370","author":"Bleecker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2017.09.004_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(06)69287-8","article-title":"Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study","volume":"368","author":"Hall","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2017.09.004_bib5","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.97.19.10483","article-title":"Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in\u00a0vivo responsiveness","volume":"97","author":"Drysdale","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pupt.2017.09.004_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01213011-200505000-00001","article-title":"Beta2-adrenoceptor gene polymorphisms","volume":"15","author":"Brodde","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pupt.2017.09.004_bib7","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1378\/chest.130.6.1873","article-title":"Pharmacogenetics of asthma","volume":"130","author":"Hall","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2017.09.004_bib8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2174\/138945012802429741","article-title":"Clinical implications of recent insights into the structural biology of beta2 adrenoceptors","volume":"13","author":"Amezcua-Gutierrez","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pupt.2017.09.004_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1165\/ajrcmb.13.1.7598936","article-title":"Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells","volume":"13","author":"Green","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pupt.2017.09.004_bib10","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1172\/JCI119874","article-title":"Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing","volume":"100","author":"Martinez","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.pupt.2017.09.004_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1164\/rccm.200409-1286OC","article-title":"Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma","volume":"171","author":"Choudhry","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FPC.0b013e328349daa1","article-title":"Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to \u03b22-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease","volume":"21","author":"Konno","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pupt.2017.09.004_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1440-1843.2008.01259.x","article-title":"Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD","volume":"13","author":"Umeda","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2017.09.004_bib14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1378\/chest.07-1103","article-title":"Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD","volume":"132","author":"Hizawa","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2017.09.004_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.rmed.2008.10.025","article-title":"Genetic association analysis of COPD candidate genes with bronchodilator responsiveness","volume":"103","author":"Kim","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib16","first-page":"CR392","article-title":"Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD","volume":"14","author":"Mokry","year":"2008","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.pupt.2017.09.004_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1183\/09031936.00111808","article-title":"Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers","volume":"33","author":"Mair","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2017.09.004_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1465-9921-13-31","article-title":"Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease","volume":"13","author":"Tanabe","year":"2012","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2017.09.004_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1475-097X.2011.01046.x","article-title":"Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease","volume":"32","author":"Lee","year":"2012","journal-title":"Clin. Physiol. Funct. Imaging"},{"key":"10.1016\/j.pupt.2017.09.004_bib21","doi-asserted-by":"crossref","first-page":"e113320","DOI":"10.1371\/journal.pone.0113320","article-title":"Impact of emphysema heterogeneity on pulmonary function","volume":"9","author":"Ju","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2017.09.004_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12931-016-0452-2","article-title":"Sirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease","volume":"17","author":"Kato","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2017.09.004_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chest.2017.03.012","article-title":"p53 signaling pathway polymorphisms associated with emphysematous changes in patients with COPD","volume":"152","author":"Mizuno","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2017.09.004_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1378\/chest.10-0984","article-title":"Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD","volume":"139","author":"de Torres","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2017.09.004_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1183\/09031936.00186311","article-title":"Computed tomography-quantified emphysema distribution is associated with lung function decline","volume":"40","author":"Mohamed Hoesein","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2017.09.004_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.121.4.1042","article-title":"Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation","volume":"121","author":"Newton","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2017.09.004_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.rmed.2008.07.025","article-title":"CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease","volume":"103","author":"Kim","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1183\/09031936.00173009","article-title":"Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD","volume":"37","author":"Kim","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2017.09.004_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201605-0997OC","article-title":"Genome-wide association study of the genetic determinants of emphysema distribution","volume":"195","author":"Boueiz","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/aje\/kwi184","article-title":"Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review","volume":"162","author":"Thakkinstian","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.pupt.2017.09.004_bib31","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/bi00198a006","article-title":"Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties","volume":"33","author":"Green","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.pupt.2017.09.004_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2040622315609251","article-title":"Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease","volume":"7","author":"George","year":"2016","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.pupt.2017.09.004_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2147\/COPD.S80992","article-title":"Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease","volume":"10","author":"Zanini","year":"2015","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"10.1016\/j.pupt.2017.09.004_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2466-12-50","article-title":"Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis","volume":"12","author":"Marson","year":"2012","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/ajrccm.162.1.9907092","article-title":"The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma","volume":"162","author":"Israel","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib36","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(04)17273-5","article-title":"Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial","volume":"364","author":"Israel","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2017.09.004_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1164\/rccm.200509-1519OC","article-title":"beta-Adrenergic receptor polymorphisms and response to salmeterol","volume":"173","author":"Wechsler","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000028397","article-title":"Pharmacogenetics of beta-1- and beta-2-adrenergic receptors","volume":"61","author":"Liggett","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.pupt.2017.09.004_bib39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI18193","article-title":"Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox","volume":"112","author":"McGraw","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.pupt.2017.09.004_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.200901-0047OC","article-title":"The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort","volume":"180","author":"Kohansal","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(09)61303-9","article-title":"Chronic obstructive pulmonary disease in non-smokers","volume":"374","author":"Salvi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2017.09.004_bib42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2169\/internalmedicine.49.3364","article-title":"Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: the Takahata study","volume":"49","author":"Osaka","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1440-1843.2006.00827.x","article-title":"Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects","volume":"11","author":"Omori","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2017.09.004_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.resinv.2015.12.002","article-title":"Respiratory failure Research group of the Japanese ministry of health, labour, and welfare, a nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan","volume":"54","author":"Seyama","year":"2016","journal-title":"Respir. Investig."},{"key":"10.1016\/j.pupt.2017.09.004_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199609193351202","article-title":"Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network","volume":"335","author":"Drazen","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.pupt.2017.09.004_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2005.12.060","article-title":"Beta-adrenoceptor responses of the airways: for better or worse?","volume":"533","author":"Broadley","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pupt.2017.09.004_bib47","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(09)61492-6","article-title":"Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial","volume":"374","author":"Wechsler","year":"2009","journal-title":"Lancet"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917301153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917301153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T06:58:26Z","timestamp":1535353106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553917301153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":47,"alternative-id":["S1094553917301153"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2017.09.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}